Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Understanding specific symptoms in different cancer stages can improve personalized care and quality of life.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Presurgical models can effectively and affordably screen cancer prevention agents.

New anti-acne medications are being tested to offer alternatives to current treatments.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Abatacept may help some people with alopecia areata regrow hair.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Latanoprost 0.1% may effectively treat hair loss.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.